Side effects of tamoxifen and raloxifene therapy

Małgorzata Sobstyl; Joanna Tkaczuk-Włach; Jacek Sobstyl; Grzegorz Jakiel

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

3/2012
vol. 11

Send email

Copy url:

abstract:

Review paper

Side effects of tamoxifen and raloxifene therapy

Małgorzata Sobstyl

,

Joanna Tkaczuk-Włach

,

Jacek Sobstyl

,

Grzegorz Jakiel

Przegląd Menopauzalny 2012; 3: 250–253

Online publish date: 2012/07/04

View full text Get citation

Tamoxifen and raloxifene belong to a group of selective estrogen receptor modulators (SERMs). Their features and therapeutic effects depend on tissue and hormonal environment in which they are acting. Advantages resulting from selectivity are used in treatment and prevention of breast cancer and osteoporosis. However, side effects of these therapies should not be neglected. The most common negative symptoms of SERMs treatment are endometrial hyperplasia and cancer, hot flashes, night sweats, vaginal atrophy, dyspareunia.

keywords:

Side effects of tamoxifen and raloxifene therapy

Małgorzata Sobstyl , Joanna Tkaczuk-Włach , Jacek Sobstyl , Grzegorz Jakiel

tamoxifen, raloxifene, breast cancer, endometrial cancer, hot flashes

Małgorzata Sobstyl

,

Joanna Tkaczuk-Włach

,

Jacek Sobstyl

,

Grzegorz Jakiel